Á lódáil...
Salvage treatment with apatinib for advanced non-small-cell lung cancer
OBJECTIVE: No definitive chemotherapeutic regimen has been established in patients with non-small-cell lung cancer (NSCLC) who failed second- or third-line treatment. The aim of this study was to evaluate apatinib, a VEGFR-2 inhibitor, in advanced NSCLC as salvage treatment. METHODS: We evaluated th...
Na minha lista:
| Foilsithe in: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Dove Medical Press
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5370069/ https://ncbi.nlm.nih.gov/pubmed/28367065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S113435 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|